Inogen Inc. (INGN)
10.32
-0.35 (-3.28%)
At close: Feb 20, 2025, 3:59 PM
10.28
-0.38%
After-hours: Feb 20, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 10.15 |
| Market Cap | 245.79M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -2.25 |
| PE Ratio (ttm) | -4.59 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 11.38 |
| Volume | 265,920 |
| Avg. Volume (20D) | 221,354 |
| Open | 10.60 |
| Previous Close | 10.67 |
| Day's Range | 10.14 - 10.70 |
| 52-Week Range | 5.82 - 13.33 |
| Beta | undefined |
About INGN
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the pa...
Industry Medical - Devices
Sector Healthcare
IPO Date Feb 14, 2014
Employees 834
Stock Exchange NASDAQ
Ticker Symbol INGN
Website https://www.inogen.com
Analyst Forecast
According to 2 analyst ratings, the average rating for INGN stock is "Hold." The 12-month stock price forecast is $7, which is a decrease of -32.17% from the latest price.
Buy 0.00%
Hold 100.00%
Sell 0.00%
Next Earnings Release
Inogen Inc. is scheduled to release its earnings on Feb 25, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+17.23%
Inogen shares are trading higher after the company...
Unlock content with
Pro Subscription
6 months ago
+35.95%
Inogen shares are trading higher after the company reported better-than-expected Q2 financial results and issued FY24 revenue guidance above estimates.
